- Issuer ticker
-
ATOS
- Reported as of
-
14 Oct 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
21 Oct 2025, 16:10:03 UTC
Filing notes and source
Key filing fact
Mark James Daniel filed Form 4 for ATOSSA THERAPEUTICS, INC. (ATOS) on 21 Oct 2025.
Key facts
- This page summarizes Mark James Daniel's Form 4 filing for ATOSSA THERAPEUTICS, INC. (ATOS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Oct 2025, 16:10.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002092593
Primary reporting owner
Daniel Mark James
- Relationship
-
Chief Financial Officer
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATOS
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +578,000
- Change %
- Price
-
$0.000000
- Shares after
- 578,000
- Date
- 14 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 578,000
- Exercise price
- $1.03
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote